galacto-Dapagliflozin Size:Contact [email protected] for quotation 1038/s41374-019-0276-z

1038/s41374-019-0276-z

7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators

87(2):162-73

2-oxazol-5-yl]acetate

CAS Number: 348-67-4

galacto-Dapagliflozin Size:Contact [email protected] for quotation 1038/s41374-019-0276-zKi = 2 nM galacto Dapagliflozin is a potent inhibitor of human SGLT2. Renal glucose transport is mediated by sodium glucose cotransporters (SGLT) 1 and 2. In humans, SGLT2 is responsible for the majority of glucose reabsorption in the kidney. In vitro: It was found that galacto dapagliflozin was a selective inhibitor of hSGLT2, but was less potent than dapagliflozin for both transporters. Both phlorizin and galacto dapagliflozin rapidly dissociated